<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals; International Council for Harmonisation; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals; International Council for Harmonisation; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-11-02 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals." The guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), formerly the International Conference on Harmonisation. The final guidance expands the testing scheme for assessing human carcinogenic risk of ph...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-23787</p>
    <p><strong>Publication Date:</strong> 2022-11-02</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/11/02/2022-23787/s1br1-addendum-to-s1b-testing-for-carcinogenicity-of-pharmaceuticals-international-council-for">https://www.federalregister.gov/documents/2022/11/02/2022-23787/s1br1-addendum-to-s1b-testing-for-carcinogenicity-of-pharmaceuticals-international-council-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-23787</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
